EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review

Elyse M Cornett, Meskerem A Nemomsa, Bailey Turbeville, Matthew A Busby, Jessica S Kaye, Aaron J Kaye, JooHee Choi, Giovanni F Ramírez, Giustino Varrassi, Adam M Kaye, Alan D Kaye, James Wilson und 1 weitere

Health Psychology Research · 11.10.2022 · 10 (5) · 1

DOI: 10.52965/001c.38536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Psychology Research, online erschienen am 11.10.2022. Verfasst von Elyse M Cornett und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, LSU Health Shreveport. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An intranasal formulation of midazolam, Nayzilam, has been FDA-approved to treat intermittent, stereotypic episodes of frequent seizure activity. Nayzilam is easy to administer and can quickly treat seizures that occur outside of the hospital. The intra-nasal route of administration allows non-medical personal to administer the drug which makes it more accessible and user-friendly in the event of a seizure. Many studies have indicated quick cessation of seizures with Nayzilam compared to rectal diazepam, which has been the standard of care treatment. Nayzilam has been proven to be safe and effective for acute seizures in children, deeming it a revolutionary alternative in times where intravenous administration is not possible.

Schlagwörter

Stichwörter der Autor:innen

NAYZILAM®intermittent seizuresmidazolamnasal spray

Autor:innen und Institutionen

  • Department of Anesthesiology, LSU Health Shreveport.
  • Department of Pharmacy Practice, Thomas J. Long School of Pharmacy, University of the Pacific.
  • Department of Anesthesiology, Medical University of South Carolina.
  • Georgetown University School of Medicine.
  • University of Central Florida College of Medicine.
  • Paolo Procacci Foundation.

Zitieren

APA

Cornett, E. M., Nemomsa, M. A., Turbeville, B., Busby, M. A., Kaye, J. S., Kaye, A. J., Choi, J., Ramírez, G. F., Varrassi, G., Kaye, A. M., Kaye, A. D., Wilson, J., & Ganti, L. (2022). Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review. Health Psychology Research, 10(5), 1. https://doi.org/10.52965/001c.38536

Vancouver

Cornett EM, Nemomsa MA, Turbeville B, Busby MA, Kaye JS, Kaye AJ, et al. Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review. Health Psychology Research. 2022;10(5):1. doi:10.52965/001c.38536

BibTeX
@article{Cornett2022,
  author = {Cornett, Elyse M and Nemomsa, Meskerem A and Turbeville, Bailey and Busby, Matthew A and Kaye, Jessica S and Kaye, Aaron J and Choi, JooHee and Ramírez, Giovanni F and Varrassi, Giustino and Kaye, Adam M and Kaye, Alan D and Wilson, James and Ganti, Latha},
  title = {Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review},
  journal = {Health Psychology Research},
  year = {2022},
  volume = {10},
  number = {5},
  pages = {1},
  doi = {10.52965/001c.38536}
}
Kostenlos starten →